EMA
OrganizationRelationship Network
062.pdf
This document is a motion filed by Jeffrey Epstein's attorneys requesting an extension until December 15, 2009, to respond to a complaint filed by Jane Doe No. 102. The reasons cited for the extension include ongoing resolution negotiations and questions arising from the 'implosion' of the Rothstein Rosenfeldt & Adler, PA firm.
EFTA00016026.pdf
This document is an email chain from December 2020 discussing extradition law, specifically concerning the enforceability of a defendant's consent to extradition from the UK to the US. The emails involve individuals from the US Department of Justice and the Crown Prosecution Service, clarifying that consent given in the US would not be binding in the UK and that a UK judge must independently verify extradition compliance with UK law. The discussion centers on a UK citizen, detained in the US, attempting to use prophylactic consent to extradition as proof of not being a flight risk for bail purposes.
DOJ-OGR-00030292.tif
This document is a page from a legal filing, listing contact information for various attorneys and their respective clients in several related court cases. It details counsel for plaintiffs, including C.M.A., and counsel for defendants Sarah Kellen and Jeffrey Epstein, along with their law firms and contact details.
DOJ-OGR-00029401.tif
This document is the third page of a Citysearch webpage, likely containing footer information. It lists various partner sites, legal disclaimers regarding Citysearch's trademark and copyright, and includes a URL with geographical coordinates and a date of December 9, 2005. The document also contains redaction markers 'b6 -8' and 'b7c -8' and a DOJ-OGR document identifier.
HOUSE_OVERSIGHT_025891.jpg
This document is a press release or investor relations update from Sanofi and Regeneron dated around July 2015, detailing clinical trial results, pricing, and regulatory milestones for the cholesterol drug Praluent. It announces a positive opinion from the European Medicine Agency and schedules an investor conference call for July 24, 2015. The document bears a 'HOUSE_OVERSIGHT' footer, suggesting it was part of a document production to Congress, likely related to pharmaceutical pricing or regulatory investigations, though it contains no direct mentions of Jeffrey Epstein or his associates in this specific page.
HOUSE_OVERSIGHT_014167.jpg
This document appears to be a contact list containing names, addresses, phone numbers, and email addresses for various individuals, many with the surname Maxwell or Mavroleon. It includes residential and work contact information across different countries, notably the UK, France, Switzerland, and the USA. The document also lists associated organizations and notes specific roles like 'assistant' or 'driver'.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity